Xalatan 0.005 Eyedrops

Xalatan 0.005 Eyedrops

Description:

Xalatan 0.005 eyedrops (XALATAN 50 mcg/ml eye drops 2.5 ml) is a prescription ophthalmic medicine containing latanoprost, a prostaglandin analogue used to lower elevated intraocular pressure. It is primarily indicated for the long-term management of open-angle glaucoma and ocular hypertension in adults and suitable adolescents, helping to prevent progressive optic nerve damage and vision loss. Xalatan is a sterile eye drop solution applied directly to the eye, formulated for once-daily use under medical supervision.

Indications:

• Treatment of open-angle glaucoma in adults and adolescents, to reduce elevated intraocular pressure (IOP).
• Management of ocular hypertension (raised pressure inside the eye) without evident glaucomatous damage, to reduce the risk of developing glaucoma.
• Helps prevent or slow progression of optic nerve damage and associated visual field loss related to high intraocular pressure.
• May be used as monotherapy or in combination with other antiglaucoma medications (such as beta-blocker eye drops) as directed by an ophthalmologist.

Active Ingredients / Key Components:

• Latanoprost – 50 mcg/ml (0.005%) ophthalmic solution.
• Other ingredients (excipients) typically include benzalkonium chloride as preservative, sodium chloride, sodium dihydrogen phosphate, disodium hydrogen phosphate, and purified water; exact full excipient list and concentrations are not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).

Dosage & Administration / How to Use:

• Usual adult dose: 1 drop in the affected eye(s) once daily, preferably in the evening, or exactly as prescribed by your ophthalmologist.
• Do not use more than once daily; more frequent dosing may reduce the pressure-lowering effect.
• Wash your hands thoroughly before use.
• Tilt your head back, gently pull down the lower eyelid to form a small pocket, and instill one drop into the conjunctival sac. Avoid touching the eye or any surface with the dropper tip.
• After instillation, close your eye gently and press a finger at the inner corner of the eye (near the nose) for 1–2 minutes to reduce systemic absorption and enhance local effect.
• If using other ophthalmic medications (drops or ointments), leave at least 5 minutes between products. Use eye ointments last.
• If a dose is missed, apply the next dose at the usual time. Do not double the dose to make up for a missed one.
• For contact lens wearers: remove lenses before instillation, wait at least 15 minutes after using the drops before reinserting lenses, as preservatives may be absorbed by soft lenses.
• Use only under medical supervision. Do not stop treatment abruptly without consulting your eye specialist, as intraocular pressure may rise again.

Clinical Benefits:

• Effectively reduces elevated intraocular pressure by increasing uveoscleral outflow of aqueous humor.
• Helps protect the optic nerve from pressure-related damage, supporting long-term preservation of vision.
• Once-daily dosing improves adherence and convenience compared with multiple-daily regimens.
• Can be used alone or in combination with other antiglaucoma agents for enhanced pressure control when monotherapy is insufficient.

Warnings & Contraindications:

• For ophthalmic use only. Do not ingest or inject.
• Contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation.
• Use with caution in patients with a history of herpetic keratitis, active intraocular inflammation (uveitis, iritis), or risk of macular edema (e.g., aphakia, pseudophakia with torn posterior lens capsule).
• Xalatan may gradually change eye color by increasing brown pigment in the iris, particularly in patients with mixed-color irises (e.g., blue-brown, green-brown, hazel-brown). This change may be permanent and usually occurs over months to years.
• May cause gradual changes in eyelashes and vellus hair around the eye (increased length, thickness, number, and pigmentation, or misdirected growth). These changes are usually reversible after discontinuation.
• Use with caution in severe asthma or history of asthma; report any worsening of respiratory symptoms to your doctor.
• Consult your doctor before use if pregnant or planning pregnancy. Latanoprost should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
• If breastfeeding, consult your physician; a decision should be made whether to discontinue nursing or discontinue the drug, considering the importance of the drug to the mother.
• Temporary blurred vision may occur after instillation; do not drive or operate machinery until vision is clear.
• Do not use if the solution changes color, becomes cloudy, or the bottle is damaged.
• Consult your doctor before use if you are taking other eye medications or have eye surgery planned or recently performed.
• Keep out of reach of children.

Side Effects:

• Common side effects: mild to moderate eye irritation, burning or stinging on instillation, eye redness (conjunctival hyperemia), itching, foreign body sensation, dry eye, or increased tearing.
• Ocular changes: gradual increase in brown pigmentation of the iris, darkening of eyelid skin, changes in eyelashes (length, thickness, number, and color), usually occurring with long-term use.
• Less common side effects: blurred vision, eye pain, eyelid edema, photophobia (sensitivity to light), conjunctivitis, or corneal changes.
• Rare but serious side effects: macular edema, uveitis/iritis, severe eye inflammation, or worsening of herpetic keratitis. Seek immediate medical attention if you experience severe eye pain, marked vision changes, or intense redness and swelling.
• Systemic side effects are uncommon but may include headache, dizziness, or mild respiratory symptoms. Report any unusual or persistent symptoms to your doctor.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Follow the storage conditions on the package insert; typically, unopened bottles may require refrigeration before first opening, while in-use bottles are usually stored below 25°c for a limited period. Do not use after the expiry date and discard any remaining solution a set number of weeks after opening, as indicated in the patient leaflet.

Specifications:

• Product type: Prescription ophthalmic antiglaucoma medicine (eye drops).
• Active ingredient concentration: latanoprost 50 mcg/ml (0.005%).
• Form: Sterile eye drops solution.
• Pack size: 2.5 ml bottle.
• Route of administration: Topical ocular (into the eye).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.